Counting the number of tumor cells positive for Ki-67 against the total number of tumor cells reveals generally higher proliferation rates among triple-negative BRCA2 tumors compared with luminal BRCA2 tumors (χ2 test; P = 0.004; Table 1; Additional File 3). The gene discussed is MKI67; the disease is neoplasm.